1. Home
  2. LVS vs EW Comparison

LVS vs EW Comparison

Compare LVS & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Las Vegas Sands Corp.

LVS

Las Vegas Sands Corp.

HOLD

Current Price

$61.82

Market Cap

45.5B

ML Signal

HOLD

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

HOLD

Current Price

$84.51

Market Cap

49.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LVS
EW
Founded
1988
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.5B
49.5B
IPO Year
2004
2000

Fundamental Metrics

Financial Performance
Metric
LVS
EW
Price
$61.82
$84.51
Analyst Decision
Buy
Buy
Analyst Count
13
20
Target Price
$67.08
$96.11
AVG Volume (30 Days)
4.7M
3.0M
Earning Date
01-28-2026
02-10-2026
Dividend Yield
1.63%
N/A
EPS Growth
9.73
N/A
EPS
2.22
2.33
Revenue
$12,264,000,000.00
$5,883,800,000.00
Revenue This Year
$13.03
$14.29
Revenue Next Year
$5.64
$9.68
P/E Ratio
$27.73
$36.41
Revenue Growth
8.37
10.60
52 Week Low
$30.18
$65.94
52 Week High
$70.46
$87.89

Technical Indicators

Market Signals
Indicator
LVS
EW
Relative Strength Index (RSI) 33.61 47.99
Support Level $64.80 $83.93
Resistance Level $65.62 $86.60
Average True Range (ATR) 1.12 1.38
MACD -0.66 -0.23
Stochastic Oscillator 16.65 25.40

Price Performance

Historical Comparison
LVS
EW

About LVS Las Vegas Sands Corp.

Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: